Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Formáid:	Conference item
Foilsithe / Cruthaithe:	2011

Míreanna comhchosúla

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
de réir: Hatch, S, et al.
Foilsithe / Cruthaithe: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
de réir: Graf, Nora, et al.
Foilsithe / Cruthaithe: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
de réir: MacGregor, T, et al.
Foilsithe / Cruthaithe: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
de réir: Hatch, S, et al.
Foilsithe / Cruthaithe: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
de réir: T. P. MacGregor, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
de réir: Sharma, R, et al.
Foilsithe / Cruthaithe: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
de réir: McHugh, PJ
Foilsithe / Cruthaithe: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
de réir: Peter J McHugh
Foilsithe / Cruthaithe: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
de réir: Mariangela Sabatella, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
de réir: Findlay, J, et al.
Foilsithe / Cruthaithe: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
de réir: Yang, J, et al.
Foilsithe / Cruthaithe: (2010)

Oesophageal and gastro-oesophageal junction tumours
de réir: Bird-Lieberman, E, et al.
Foilsithe / Cruthaithe: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
de réir: Anwaar Ahmad, et al.
Foilsithe / Cruthaithe: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
de réir: Findlay, J, et al.
Foilsithe / Cruthaithe: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
de réir: den Boer, RB, et al.
Foilsithe / Cruthaithe: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
de réir: Ming-Yii Huang, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
de réir: Abdullah, U
Foilsithe / Cruthaithe: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
de réir: Shibo Li, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
de réir: Millo, J, et al.
Foilsithe / Cruthaithe: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
de réir: Kaina Bernd, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
de réir: Thomas, A, et al.
Foilsithe / Cruthaithe: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
de réir: Sile Li, et al.
Foilsithe / Cruthaithe: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
de réir: Bhagwat, N, et al.
Foilsithe / Cruthaithe: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
de réir: Maryam Faridounnia, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
de réir: Jiajia Wang, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
de réir: Wang, A, et al.
Foilsithe / Cruthaithe: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
de réir: Wang, A, et al.
Foilsithe / Cruthaithe: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
de réir: A. G. M. T. Powell, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
de réir: Findlay, J, et al.
Foilsithe / Cruthaithe: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
de réir: Jing Xue, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
de réir: Xin Zhang, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
de réir: Rana, M, et al.
Foilsithe / Cruthaithe: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
de réir: Matheus Treuk Medeiros de Araújo
Foilsithe / Cruthaithe: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
de réir: Mukherjee, S, et al.
Foilsithe / Cruthaithe: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
de réir: Gillies, R, et al.
Foilsithe / Cruthaithe: (2010)